ACCEPTED MANUSCRIPT
washed with brine (5 mL) and dried over anhyd. Na2SO4. The crude residue obtained after
evaporation of the solvent was purified by silica gel column chromatography using petroleum
ether/EtOAc (7:3) as eluent to afford 21 (0.08 g, 82%) as a colorless solid; Rf 0.70 (60%
EtOAc/petroleum ether); mp: 62-63 °C; [α]D: −86.9 (c 1.0, CHCl3); IR (KBr): 2918, 1471, 1422,
1353, 1065 cm-1; 1H NMR (400 MHz, CDCl3):
= 15.6, 5.2 Hz, 2H), 3.43 (dd, J = 15.6, 6.4 Hz, 2H), 3.30-3.08 (m, 4H), 1.17 (s, 18H); C NMR
δ 5.89-5.70 (m, 2H), 5.40-5.15 (m, 4H), 3.79 (dd, J
13
(100 MHz, CDCl3): 134.3, 118.4, 57.9, 50.3, 47.3, 22.9 (3×CH3); HRMS M+Na found:
δ
371.1804. C16H32N2O2S2+Na requires 371.1803.
Typical Procedure for the 1, 4-Addition of Boronic Acids to Cyclic Enones: The ligand 1a
(0.0035 g, 0.01 mmol), [Rh(C2H4)2Cl]2 (0.0038 g, 0.01 mmol) and PhB(OH)2 (0.24 g, 2 mmol)
were dissolved in dry THF and stirred for 1 h at 60 °C. To this solution the α,β-unsaturated
carbonyl compound (0.1 mL, 1.00 mmol) and an aqueous solution of K3PO4 (0.33 mL of 1.5 M, 0.5
mmol) were added in sequence to the reaction mixture and was further stirred at 60 °C. After
completion of the reaction (TLC), it was evaporated in vacuo to give the crude residue which was
purified by silica gel column chromatography to yield the product 3-aryl alkenone. The procedure
described above is representative for the following compounds.
(R)-3-phenylcyclohexan-1-one (18): colorless oil; Yield 95%; er (R:S) 96:4. Enantiomeric ratio
was determined by chiral HPLC analysis (CHIRALCEL OD-H, 1.5% IPA in hexane, 0.5 mL/min,
254 nm UV detector). tR = 20.64 min for (R) and tR = 21.81min for (S); [α]D: +20.1 (c 0.58, CHCl3);
1H NMR (400 MHz, CDCl3):
(m, 4H), 2.18-1.96 (m, 2H), 1.92-1.69 (m, 2H); C NMR (100 MHz, CDCl3):
129.4, 128.5, 126.4 , 48.7, 44.6 , 41.0, 32.5 , 25.4.
δ 7.42-7.28 (m, 2H), 7.28-7.13 (m, 3H), 3.05-2.92 (m, 1H), 2.63-2.28
13
δ 211.4, 144.1,
(R)-3-(m-tolyl) cyclohexan-1-one (18a): colorless oil; Yield 93%; er (R:S) 95:5. Enantiomeric
ratio was determined by chiral HPLC analysis (CHIRALCEL OD-H, 5% IPA in hexane, 0.7
mL/min, 254 nm UV detector). tR = 7.45 min for (R) and tR = 8.44 min for (S); [α]D: +17.4 (c 0.55,
CHCl3); 1H NMR (400 MHz, CDCl3):
δ
7.31-7.15 (m, 1H), 7.07-6.97 (m, 3H), 3.09-2.86 (m, 1H),
2.66-2.36 (m, 4H), 2.34 (s, 3H), 2.20-2.02 (m, 2H), 1.90-1.68 (m, 2H); 13C NMR (100 MHz,
CDCl3): 211.1, 144.3, 138.2, 128.5, 127.4, 127.3, 123.5, 48.9, 44.4, 41.1, 32.8, 25.5, 21.4.
δ
(R)-3-(3-fluorophenyl) cyclohexan-1-one (18b): colorless oil; Yield 70%; er (R:S) 98:2
Enantiomeric ratio was determined by chiral HPLC analysis (CHIRALPAK AD-H, 5% IPA in
hexane, 0.8 mL/min, 254 nm UV detector). tR = 6.19 min for (R) and tR = 6.95min for (S); [α]D:
+15.8 (c 0.6, CHCl3); 1H NMR (400 MHz, CDCl3):
δ
7.45-7.17 (m, 1H), 7.00 (d, J = 7.6 Hz, 1H),
6.97-6.85 (m, 2H), 3.14-2.92 (m, 1H), 2.72-2.27 (m, 4H), 2.24-1.98 (m, 2H), 1.97-1.67 (m, 2H);
13C NMR (100 MHz, CDCl3):
210.4, 162.9 (d, J = 244.4 Hz), 146.8 (d, J = 6.8 Hz), 130.1 (d, J =
δ
8.4 Hz), 122.2 (d, J = 2.8 Hz), 113.5 (d, J = 5.6 Hz), 113.3 (d, J = 5.8 Hz), 48. 6 (CH2), 44.3 (d, J =
1.6 Hz), 41.0, 32.5, 25.3.
(R)-3-(4-methoxyphenyl) cyclohexan-1-one (18c): White solid; Yield 93%; er (R:S) 96:4.
Enantiomeric ratio was determined by chiral HPLC analysis (CHIRALPAK AD-H, 2% IPA in
hexane, 0.3 mL/min, 254 nm UV detector). tR = 17.27 min for (R) and tR = 18.06 min for (S); [α]D:
+13.8 (c 0.99, CHCl3); 1H NMR (400 MHz, CDCl3):
δ
7.14 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz,
2H), 3.78 (s, 3H), 3.10-2.86 (m, 1H), 2.60-2.29 (m, 4H), 2.21-1.96 (m, 2H), 1.93-1.67 (m, 2H); 13C
NMR (100 MHz, CDCl3): 211.1, 158.1, 136.4, 127.3, 113.9, 55.1, 49.1, 43.8, 41.0, 32.9, 25.3.
δ
(R)-3-phenylcyclopentan-1-one (22a): colorless oil; Yield 95%; er (R:S) 99:1 Enantiomeric ratio
was determined by chiral HPLC analysis (CHIRALPAK AD-H, 0.2% IPA in hexane, 0.5 mL/min,
254 nm UV detector). tR = 39.60 min for (R) and tR = 43.98 min for (S); [α]D: +86.1 (c 0.65,
CHCl3); 1H NMR (400 MHz, CDCl3):
2.63 (dd, J = 18.2, 7.6 Hz, 1H), 2.53-2.20 (m, 4H), 2.05-1.84 (m, 1H); C NMR (100 MHz,
δ 7.42-7.30 (m, 2H), 7.29-7.20 (m, 3H), 3.52-3.30 (m, 1H),
13
CDCl3):
δ
218.1, 142.9, 128.4, 126.52, 126.49, 45.5, 42.0, 38.6, 31.0.
12